Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-01-07 CHANG LINDA L SVP, CFO & Secretary Exercise or conversion +29,600 $1.13 $33K 59,600
2015-01-07 CHANG LINDA L SVP, CFO & Secretary Sale −29,600 $2.10 $62K 30,000
2015-01-07 CHANG LINDA L SVP, CFO & Secretary Exercise or conversion · Option to Purchase −29,600 45,400
2014-12-08 CHANG LINDA L SVP, CFO & Secretary Grant or award · Stock options (right to buy) +186,207 186,207
2014-01-29 CHANG LINDA L SVP & CFO Grant or award · Stock Options (right to buy) +210,000 210,000
2012-12-03 CHANG LINDA L SVP & CFO Grant or award · Stock Options (right to buy) +75,000 75,000
2011-11-16 CHANG LINDA L SVP & CFO Purchase +10,000 $1.38 $14K 30,000

Page 1 of 1 · 7 trades